Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
I. Karampela (Chaidari, Greece), E. Kandri (Athens, Greece), G. Christodoulatos (Athens, Greece), G. Skyllas (Chaidari, Greece), E. Chrysanthopoulou (Chaidari, Greece), G. Antonakos (Chaidari, Greece), E. Voyatzakis (Athens, Greece), A. Armaganidis (Chaidari, Greece), M. Dalamaga (Athens, Greece). Circulating eNAMPT and resistin as emerging biomarkers in sepsis. 2305

Member's Comments

No comment yet.

Related content which might interest you: Circulating total leptin as a diagnostic and prognostic biomarker in sepsis Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019 Serum kinetics of total leptin and soluble leptin receptor as prognostic tools in sepsis. Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure Year: 2019 Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease? Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Visfatin as a possible serum biomarker in COPD Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Role of serum adiponectin in COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 The role of leptin and adiponectin in patients with COPD Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Circulating endothelin-1 levels in patients with COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 Biomarkers in COPD- The role of resistin and leptin Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Leptin and adiponectin levels in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Serum levels of circulating adipocytokines, leptin and adiponectin, in obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004 Serum endostatin as a genetically-influenced biomarker in PAH Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma Source: Annual Congress 2009 - Novel approaches in asthma Year: 2009 Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017 Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 Serum TNFα and IL8 as markers of systemic inflammation in severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005